← All stocks

Lantheus Holdings, Inc.

LNTH Net selling
CIK 0001521036 #1173 in the set updated 17 Sep 2026
Bought (120 mo)
$141.20K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$840.06M
$32.74M on a plan · $17.03M straight out of an exercise
Sold at will
$790.29M
288 of 384 sales
Net
−$839.92M
−$790.15M against sales at will

By person

39 insiders · 395 transactions
281×

Mary Anne Heino holds 281 times base salary in stock. $28.14M of shares against $100.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Mary Anne Heino last reported holding, valued at $56.15, the price Common Stock was last bought or sold at on the open market here, on 20 Aug 2025.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
FARALLON PARTNERS L L C/CA entity
10% owner
$191.21M (2)
−$191.21M
3,477,227
5.33%
$195.25M
−49.5%
PATEL RAJIV A
Member of a Group Owning 10%
$191.21M (2)
−$191.21M
3,477,227
5.33%
$195.25M
−49.5%
Burgstahler David F
Director
$154.91M (40)
−$154.91M
51,517
0.0789%
$2.89M
−99.7%
Avista Capital Partners GP, LLC entity
10% owner
$146.34M (20)
−$146.34M
122,492
0.1877%
$6.88M
−99.3%
Venkataraman Sriram
Director
$59.10M (6)
−$59.10M
3,442,208
5.27%
$193.28M
−61.5%
Heino Mary Anne
Executive Chair and CEO
$41.33M (75)
−$41.33M
501,197
0.7679%
$28.14M
+25.9%
Marshall Robert J. Jr.
CFO and Treasurer
$14.08M (28) scheduled
−$14.08M
122,071
0.1870%
$6.85M
MARKISON BRIAN A
CEO
$6.52M (19) scheduled
−$6.52M
232,420
0.3561%
$13.05M
+208.0%
Montagut Etienne
Chief Business Officer
$4.93M (15)
−$4.93M
94,651
0.1450%
$5.31M
−1.9%
Niedzwiecki Daniel
See Remarks
$4.78M (15) scheduled
−$4.78M
117,465
0.1800%
$6.60M
+143.7%
Blanchfield Paul
President
$4.20M (19) scheduled
−$4.20M
108,214
0.1658%
$6.08M
+2,282%
DUFFY MICHAEL P
SVP and General Counsel
$4.08M (24)
−$4.08M
109,472
0.1677%
$6.15M
−22.6%
LENO SAM R
Director
$3.02M (14) scheduled
−$3.02M
67,246
0.1030%
$3.78M
+44.4%
Orlandi Cesare
Chief Medical Officer
$2.32M (18)
−$2.32M
68,483
0.1049%
$3.85M
−28.7%
Sabens Andrea
Chief Accounting Officer
$2.07M (36)
−$2.07M
60,420
0.0926%
$3.39M
−12.3%
SCHAFFER DERACE L
Director
$1.62M (10)
−$1.62M
25,089
0.0384%
$1.41M
−66.5%
Ber Gerard
Director
$1.57M (4) scheduled
−$1.57M
27,499
0.0421%
$1.54M
+7,118%
McHugh Julie
Director
$1.34M (8)
−$1.34M
30,099
0.0461%
$1.69M
Walker Carol
Senior Vice President, Quality
$1.34M (4)
−$1.34M
64,899
0.0994%
$3.64M
−15.0%
Maeusli Heinz Christoph
Director
$141.20K (8)
$1.45M (4) scheduled
−$1.31M
30,014
0.0460%
$1.69M
Pruden Gary J
Director
$1.26M (2) scheduled
−$1.26M
21,287
0.0326%
$1.20M
Healey Timothy G
SVP, Commercial
$456.31K (3)
−$456.31K
85,658
0.1312%
$4.81M
+27.8%
Thrall James H
Director
$273.00K (3) scheduled
−$273.00K
39,881
0.0611%
$2.24M
Crowley John W.
CFO
$215.28K (2)
−$215.28K
161,825
0.2479%
$9.09M
+20.4%
Bolla John J.
Chief Operations Officer
$214.79K (7)
−$214.79K
102,440
0.1569%
$5.75M
Robertson A Frederick
Director
$131.73K (2)
−$131.73K
51,798
0.0794%
$2.91M
+107.2%
Molnar Istvan
Chief Medical Officer
$74.10K (1)
−$74.10K
58,950
0.0903%
$3.31M
+37,448%
Baylor-Henry Minnie
Director
$517.35 (1)
−$517.35
14,034
0.0215%
$788.01K
Dawes William C. Jr.
VP, Mfg & Ops
111,581
0.1709%
$6.27M
+19.8%
Morgan Amanda Michelle
Chief Commercial Officer
64,153
0.0983%
$3.60M
+150.1%
Clemmer James C
Director
62,082
0.0951%
$3.49M
+94.0%
Provost Jean-Claude
Chief Medical Officer
38,841
0.0595%
$2.18M
+770.1%
Dinkelborg Ludger
See Remarks
33,195
0.0509%
$1.86M
Yao Ying Vivian
Chief Human Resources Officer
30,319
0.0464%
$1.70M
Pucel Kenneth
Director
21,359
0.0327%
$1.20M
Brown Kimberly
Chief Accounting Officer
13,263
0.0203%
$744.72K
Humphrey Jeffrey
Chief Medical Officer
9,076
0.0139%
$509.62K
EASTLAND JULIA MARIE
Director
8,019
0.0123%
$450.27K
Morrow Phuong Khanh
Director
7,237
0.0111%
$406.36K
Insider
Date
Role
Action
Shares
Price
Amount
MARKISON BRIAN A
19 Dec 2024
CEO
Exercised, kept
16,666
$6.00
$100.00K
MARKISON BRIAN A
19 Dec 2024
CEO
Exercised, kept
16,102
$12.42
$199.99K
LENO SAM R
31 Mar 2022
Director
Exercised, kept
4,448
$23.04
$102.48K
Showing 250 of 395 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 497
Amendments (4/A) skipped 11
Filings about a different issuer 5
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 67
Sales straight out of an exercise 29
Sales at will 288
Transactions with no price 0
Shares from compensation/vesting 15,315,547
Sales filed before the plan box existed 279
History held since 2 Sep 2016